7.39MMarket Cap-936P/E (TTM)
0.450High0.415Low156.80KVolume0.421Open0.417Pre Close65.56KTurnover1.64%Turnover RatioLossP/E (Static)16.79MShares0.94052wk High2.68P/B4.20MFloat Cap0.35052wk Low--Dividend TTM9.55MShs Float126.260Historical High--Div YieldTTM8.37%Amplitude0.350Historical Low0.418Avg Price1Lot Size
Shuttle Pharmaceuticals Stock Forum
Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), known for its innovative approach in enhancing cancer treatments through radiation therapy, has announced promising developments with one of its pre-clinical assets, SP-1-303. The selective histone deacetylase (HDAC) inhibitor has demonstra...
Ill buy when it dips more. Shorts haven’t completely covered yet. They aint done with their greed.
$Shuttle Pharmaceuticals(SHPH.US)$ huge opportunity
$Shuttle Pharmaceuticals(SHPH.US)$ fly👍🚀🚀🚀🚀
fly
Shuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE
Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) has announced the publication of a manuscript in PLOS ONEdetailing the effectiveness of their pre-clinical HDAC inhibitor asset, SP-1-303. The study shows that SP-1-303 activates ATM protein...
No comment yet